Erez Moshe Bublil

Title: Erez Moshe Bublil: Innovator in Antibody Research

Introduction

Erez Moshe Bublil is a notable inventor based in Holon, Israel. He has made significant contributions to the field of antibody research, particularly in the mapping and reconstitution of conformational discontinuous binding surfaces. His work has implications for vaccine development, especially in the context of HIV.

Latest Patents

Erez holds 2 patents, with his latest focusing on the structure of conformational, discontinuous binding surfaces that associate with binding molecules, specifically the epitopes of monoclonal antibodies (mAbs). This innovative approach utilizes a novel computer algorithm to analyze the crystalline structure of original binding surfaces, allowing for the selection of specific peptides from a peptide library. The research aims to reconstitute antigenic epitope-mimetics recognized by their original mAbs, which can be crucial in developing vaccines for preventing or treating HIV.

Career Highlights

Erez is affiliated with Ramot at Tel-Aviv University Ltd., where he continues to advance his research in antibody binding surfaces. His work is characterized by a strong emphasis on the intersection of computational analysis and biological applications.

Collaborations

Erez has collaborated with esteemed colleagues such as Jonathan M. Gershoni and Dimitri Denisov, contributing to a rich environment of innovation and research.

Conclusion

Erez Moshe Bublil's work exemplifies the critical role of inventors in advancing scientific knowledge and developing solutions for global health challenges. His contributions to antibody research are paving the way for future innovations in vaccine development.